Chongqing Lummy Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 891.7 million compared to CNY 1,071.62 million a year ago. Revenue was CNY 891.7 million compared to CNY 1,071.62 million a year ago. Net income was CNY 19.97 million compared to CNY 0.544836 million a year ago. Basic earnings per share from continuing operations was CNY 0.0205 compared to CNY 0.0007 a year ago. Diluted earnings per share from continuing operations was CNY 0.0205 compared to CNY 0.0007 a year ago.